Overview

Trial of Effects of Oral Xyrem and Zolpidem on Sleep-Disordered Breathing in Obstructive Sleep Apnea Patients

Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
To study the effect of Xyrem (9 g), Xyrem (9 g) plus modafinil 200 mg administered the morning prior to Xyrem, positive control (zolpidem 10 mg), and placebo on the frequency and outcome of events of sleep-disordered breathing in patients with obstructive sleep apnea syndrome (OSAS).
Phase:
Phase 4
Details
Lead Sponsor:
Jazz Pharmaceuticals
Treatments:
Armodafinil
Modafinil
Sodium Oxybate
Zolpidem